{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:44:55Z","timestamp":1793724295051,"version":"4.6.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2013,5,15]],"date-time":"2013-05-15T00:00:00Z","timestamp":1368576000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1007\/s40264-013-0063-5","type":"journal-article","created":{"date-parts":[[2013,5,14]],"date-time":"2013-05-14T11:17:10Z","timestamp":1368530230000},"page":"565-572","source":"Crossref","is-referenced-by-count":46,"title":["A Potential Event-Competition Bias in Safety Signal Detection: Results from a Spontaneous Reporting Research Database in France"],"prefix":"10.1007","volume":"36","author":[{"given":"Francesco","family":"Salvo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florent","family":"Leborgne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frantz","family":"Thiessard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"B\u00e9gaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Pariente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,5,15]]},"reference":[{"key":"63_CR1","doi-asserted-by":"crossref","unstructured":"Bombardier C, Laine L, Reicin A, Shapiro D, Burgos-Vargas R, Davis B, et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med. 2000;343(21):1520\u20138 (2 p following 8).","DOI":"10.1056\/NEJM200011233432103"},{"issue":"12","key":"63_CR2","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1002\/pds.2044","volume":"19","author":"A Weill","year":"2010","unstructured":"Weill A, Paita M, Tuppin P, Fagot JP, Neumann A, Simon D, et al. Benfluorex and valvular heart disease: a cohort study of a million people with diabetes mellitus. Pharmacoepidemiol Drug Saf. 2010;19(12):1256\u201362.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"63_CR3","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2165\/00002018-200326030-00003","volume":"26","author":"M Hauben","year":"2003","unstructured":"Hauben M, Zhou X. Quantitative methods in pharmacovigilance: focus on signal detection. Drug Saf. 2003;26(3):159\u201386.","journal-title":"Drug Saf"},{"issue":"7","key":"63_CR4","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/pds.2155","volume":"20","author":"ZP Qureshi","year":"2011","unstructured":"Qureshi ZP, Seoane-Vazquez E, Rodriguez-Monguio R, Stevenson KB, Szeinbach SL. Market withdrawal of new molecular entities approved in the United States from 1980 to 2009. Pharmacoepidemiol Drug Saf. 2011;20(7):772\u20137.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"63_CR5","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/pds.1058","volume":"14","author":"N Moore","year":"2005","unstructured":"Moore N, Thiessard F, Begaud B. The history of disproportionality measures (reporting odds ratio, proportional reporting rates) in spontaneous reporting of adverse drug reactions. Pharmacoepidemiol Drug Saf. 2005;14(4):285\u20136.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"63_CR6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2165\/00002018-199410020-00001","volume":"10","author":"IR Edwards","year":"1994","unstructured":"Edwards IR, Biriell C. Harmonisation in pharmacovigilance. Drug Saf. 1994;10(2):93\u2013102.","journal-title":"Drug Saf"},{"issue":"4","key":"63_CR7","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s002280050466","volume":"54","author":"A Bate","year":"1998","unstructured":"Bate A, Lindquist M, Edwards IR, Olsson S, Orre R, Lansner A, et al. A Bayesian neural network method for adverse drug reaction signal generation. Eur J Clin Pharmacol. 1998;54(4):315\u201321.","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"63_CR8","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/00031305.1999.10474456","volume":"53","author":"W Dumouchel","year":"1999","unstructured":"Dumouchel W. Bayesian data mining in large frequency tables, with an application to the FDA spontaneous reporting system. Am Stat. 1999;53(3):177\u201390.","journal-title":"Am Stat"},{"key":"63_CR9","doi-asserted-by":"crossref","unstructured":"Waller P, van Puijenbroek E, Egberts A, Evans S. The reporting odds ratio versus the proportional reporting ratio: \u2018deuce\u2019. Pharmacoepidemiol Drug Saf. 2004;13(8):525\u20136 (discussion 7\u20138).","DOI":"10.1002\/pds.1002"},{"issue":"4","key":"63_CR10","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1109\/TITB.2005.855566A","volume":"9","author":"E Roux","year":"2005","unstructured":"Roux E, Thiessard F, Fourrier A, Begaud B, Tubert-Bitter P. Evaluation of statistical association measures for the automatic signal generation in pharmacovigilance. IEEE Trans Infect Technol Biomed. 2005;9(4):518\u201327.","journal-title":"IEEE Trans Infect Technol Biomed"},{"issue":"1","key":"63_CR11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/pds.668","volume":"11","author":"EP Puijenbroek van","year":"2002","unstructured":"van Puijenbroek EP, Bate A, Leufkens HG, Lindquist M, Orre R, Egberts AC. A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions. Pharmacoepidemiol Drug Saf. 2002;11(1):3\u201310.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"10","key":"63_CR12","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/BF03261981","volume":"35","author":"A Pariente","year":"2012","unstructured":"Pariente A, Avillach P, Salvo F, Thiessard F, Miremont-Salame G, Fourrier-Reglat A, et al. Effect of competition bias in safety signal generation: analysis of a research database of spontaneous reports in France. Drug Saf. 2012;35(10):855\u201364.","journal-title":"Drug Saf"},{"issue":"7","key":"63_CR13","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/pds.771","volume":"12","author":"AL Gould","year":"2003","unstructured":"Gould AL. Practical pharmacovigilance analysis strategies. Pharmacoepidemiol Drug Saf. 2003;12(7):559\u201374.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"12","key":"63_CR14","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.2165\/11584390-000000000-00000","volume":"33","author":"HW Wang","year":"2010","unstructured":"Wang HW, Hochberg AM, Pearson RK, Hauben M. An experimental investigation of masking in the US FDA adverse event reporting system database. Drug Saf. 2010;33(12):1117\u201333.","journal-title":"Drug Saf"},{"issue":"11","key":"63_CR15","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/pds.2022","volume":"19","author":"A Pariente","year":"2010","unstructured":"Pariente A, Didailler M, Avillach P, Miremont-Salame G, Fourrier-Reglat A, Haramburu F, et al. A potential competition bias in the detection of safety signals from spontaneous reporting databases. Pharmacoepidemiol Drug Saf. 2010;19(11):1166\u201371.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"8","key":"63_CR16","doi-asserted-by":"crossref","first-page":"731","DOI":"10.2165\/00002018-200528080-00007","volume":"28","author":"F Thiessard","year":"2005","unstructured":"Thiessard F, Roux E, Miremont-Salame G, Fourrier-Reglat A, Haramburu F, Tubert-Bitter P, et al. Trends in spontaneous adverse drug reaction reports to the French pharmacovigilance system (1986\u20132001). Drug Saf. 2005;28(8):731\u201340.","journal-title":"Drug Saf"},{"issue":"1","key":"63_CR17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/157488607779315516","volume":"2","author":"A Conforti","year":"2007","unstructured":"Conforti A, Chiamulera C, Moretti U, Colcera S, Fumagalli G, Leone R. Musculoskeletal adverse drug reactions: a review of literature and data from ADR spontaneous reporting databases. Curr Drug Saf. 2007;2(1):47\u201363.","journal-title":"Curr Drug Saf"},{"issue":"4","key":"63_CR18","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1055\/s-2005-916670","volume":"31","author":"JD Tiaden","year":"2005","unstructured":"Tiaden JD, Wenzel E, Berthold HK, Muller-Oerlinghausen B. Adverse reactions to anticoagulants and to antiplatelet drugs recorded by the German spontaneous reporting system. Semin Thromb Hemost. 2005;31(4):371\u201380.","journal-title":"Semin Thromb Hemost"},{"issue":"3","key":"63_CR19","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/00126334-200003010-00004","volume":"23","author":"P Bonfanti","year":"2000","unstructured":"Bonfanti P, Valsecchi L, Parazzini F, Carradori S, Pusterla L, Fortuna P, et al. Incidence of adverse reactions in HIV patients treated with protease inhibitors: a cohort study. Coordinamento Italiano Studio Allergia e Infezione da HIV (CISAI) Group. J Acquir Immune Defic Syndr. 2000;23(3):236\u201345.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"63_CR20","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1177\/026988110101500405","volume":"15","author":"PN Biswasl","year":"2001","unstructured":"Biswasl PN, Wilton LV, Pearcel GL, Freemantle S, Shakir SA. The pharmacovigilance of olanzapine: results of a post-marketing surveillance study on 8858 patients in England. J Psychopharmacol. 2001;15(4):265\u201371.","journal-title":"J Psychopharmacol"},{"key":"63_CR21","unstructured":"MMSSO. Introductory Guide MedDRA Version 14.0. Chantilly, Virginia2011. http:\/\/www.meddramsso.com\/files_acrobat\/intguide_14_0_English_update.pdf ."},{"issue":"5","key":"63_CR22","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1046\/j.1365-2125.1997.00615.x","volume":"44","author":"N Moore","year":"1997","unstructured":"Moore N, Kreft-Jais C, Haramburu F, Noblet C, Andrejak M, Ollagnier M, et al. Reports of hypoglycaemia associated with the use of ACE inhibitors and other drugs: a case\/non-case study in the French pharmacovigilance system database. Br J Clin Pharmacol. 1997;44(5):513\u20138.","journal-title":"Br J Clin Pharmacol"},{"issue":"12","key":"63_CR23","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1016\/j.ijmedinf.2009.01.001","volume":"78","author":"RK Pearson","year":"2009","unstructured":"Pearson RK, Hauben M, Goldsmith DI, Gould AL, Madigan D, O\u2019Hara DJ, et al. Influence of the MedDRA hierarchy on pharmacovigilance data mining results. Int J Med Inform. 2009;78(12):e97\u2013103.","journal-title":"Int J Med Inform"},{"issue":"6","key":"63_CR24","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2165\/0129784-200808060-00004","volume":"8","author":"BA Golomb","year":"2008","unstructured":"Golomb BA, Evans MA. Statin adverse effects: a review of the literature and evidence for a mitochondrial mechanism. Am J Cardiovasc Drugs. 2008;8(6):373\u2013418.","journal-title":"Am J Cardiovasc Drugs"},{"issue":"8","key":"63_CR25","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1346-8138.1997.tb02839.x","volume":"24","author":"Y Horiuchi","year":"1997","unstructured":"Horiuchi Y, Maruoka H. Petechial eruptions due to simvastatin in a patient with diabetes mellitus and liver cirrhosis. J Dermatol. 1997;24(8):549\u201351.","journal-title":"J Dermatol"},{"issue":"9145","key":"63_CR26","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1016\/S0140-6736(05)61366-9","volume":"352","author":"PR Koduri","year":"1998","unstructured":"Koduri PR. Simvastatin and thrombotic thrombocytopenic purpura. Lancet. 1998;352(9145):2020.","journal-title":"Lancet"},{"issue":"9136","key":"63_CR27","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/S0140-6736(05)70492-X","volume":"352","author":"LJ McCarthy","year":"1998","unstructured":"McCarthy LJ, Porcu P, Fausel CA, Sweeney CJ, Danielson CF. Thrombotic thrombocytopenic purpura and simvastatin. Lancet. 1998;352(9136):1284\u20135.","journal-title":"Lancet"},{"issue":"4","key":"63_CR28","first-page":"357","volume":"77","author":"G Possamai","year":"1992","unstructured":"Possamai G, Bovo P, Santonastaso M. Thrombocytopenic purpura during therapy with simvastatin. Haematologica. 1992;77(4):357\u20138.","journal-title":"Haematologica"},{"issue":"11","key":"63_CR29","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1001\/archinte.1990.00390220135030","volume":"150","author":"S Ahmad","year":"1990","unstructured":"Ahmad S. Lovastatin. Warfarin interaction. Arch Intern Med. 1990;150(11):2407.","journal-title":"Arch Intern Med"},{"issue":"12","key":"63_CR30","first-page":"31","volume":"98","author":"EA Iliadis","year":"1995","unstructured":"Iliadis EA, Konwinski MF. Lovastatin during warfarin therapy resulting in bleeding. Pa Med. 1995;98(12):31.","journal-title":"Pa Med"},{"issue":"Suppl 2","key":"63_CR31","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1007\/s10067-008-1020-z","volume":"27","author":"M Haroon","year":"2008","unstructured":"Haroon M, Devlin J. A case of ANCA-associated systemic vasculitis induced by atorvastatin. Clin Rheumatol. 2008;27(Suppl 2):S75\u20137.","journal-title":"Clin Rheumatol"},{"key":"63_CR32","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s00228-012-1218-5","volume":"68","author":"G Roberto","year":"2012","unstructured":"Roberto G, Biagi C, Montanaro N, Koci A, Moretti U, Motola D. Statin-associated gynecomastia: evidence coming from the Italian spontaneous ADR reporting database and literature. Eur J Clin Pharmacol. 2012;68:1007\u201311.","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"63_CR33","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1055\/s-2007-996428","volume":"25","author":"S Ehrenforth","year":"1999","unstructured":"Ehrenforth S, Schenk JF, Scharrer I. Liver damage induced by coumarin anticoagulants. Semin Thromb Hemost. 1999;25(1):79\u201383.","journal-title":"Semin Thromb Hemost"},{"issue":"3","key":"63_CR34","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0168-8278(05)80326-5","volume":"21","author":"T Hohler","year":"1994","unstructured":"Hohler T, Schnutgen M, Helmreich-Becker I, Mayet WJ, Mayer zum Buschenfelde KH. Drug-induced hepatitis: a rare complication of oral anticoagulants. J Hepatol. 1994;21(3):447\u20139.","journal-title":"J Hepatol"},{"issue":"678","key":"63_CR35","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1136\/pgmj.58.678.233","volume":"58","author":"AJ Howitt","year":"1982","unstructured":"Howitt AJ, Williams AJ, Skinner C. Warfarin-induced vasculitis: a dose-related phenomenon in susceptible individuals? Postgrad Med J. 1982;58(678):233\u20134.","journal-title":"Postgrad Med J"},{"issue":"6","key":"63_CR36","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1159\/000250797","volume":"158","author":"M Stavorovsky","year":"1979","unstructured":"Stavorovsky M, Lichtenstein D, Nissim F. Skin petechiae and ecchymoses (vasculitis) due to anticoagulant therapy. Dermatologica. 1979;158(6):451\u201361.","journal-title":"Dermatologica"},{"issue":"3","key":"63_CR37","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000249938","volume":"165","author":"A Tanay","year":"1982","unstructured":"Tanay A, Yust I, Brenner S, Koffler M, Abramov AL. Dermal vasculitis due to coumadin hypersensitivity. Dermatologica. 1982;165(3):178\u201385.","journal-title":"Dermatologica"},{"issue":"6","key":"63_CR38","first-page":"828","volume":"20","author":"S Nakamizo","year":"2010","unstructured":"Nakamizo S, Egawa G, Arakawa A, Miyachi Y, Kabashima K. Warfarin-induced alopecia after repeated chemotherapy. Eur J Dermatol. 2010;20(6):828\u20139.","journal-title":"Eur J Dermatol"},{"issue":"1","key":"63_CR39","first-page":"63","volume":"42","author":"J Umlas","year":"1988","unstructured":"Umlas J, Harken DE. Warfarin-induced alopecia. Cutis. 1988;42(1):63\u20134.","journal-title":"Cutis"},{"issue":"6","key":"63_CR40","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1001\/archpedi.1975.02120430050014","volume":"129","author":"CK Ho","year":"1975","unstructured":"Ho CK, Kaufman RL, McAlister WH. Congenital malformations. Cleft palate, congenital heart disease, absent tibiae, and polydactyly. Am J Dis Child. 1975;129(6):714\u20136.","journal-title":"Am J Dis Child"},{"issue":"3","key":"63_CR41","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2165\/00002018-200730030-00006","volume":"30","author":"D Coppola","year":"2007","unstructured":"Coppola D, Russo LJ, Kwarta RF Jr, Varughese R, Schmider J. Evaluating the postmarketing experience of risperidone use during pregnancy: pregnancy and neonatal outcomes. Drug Saf. 2007;30(3):247\u201364.","journal-title":"Drug Saf"},{"issue":"2","key":"63_CR42","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S1386-6532(02)00118-X","volume":"26","author":"CL Cherry","year":"2003","unstructured":"Cherry CL, McArthur JC, Hoy JF, Wesselingh SL. Nucleoside analogues and neuropathy in the era of HAART. J Clin Virol. 2003;26(2):195\u2013207.","journal-title":"J Clin Virol"},{"issue":"14","key":"63_CR43","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1097\/00002030-200309260-00005","volume":"17","author":"J Gerstoft","year":"2003","unstructured":"Gerstoft J, Kirk O, Obel N, Pedersen C, Mathiesen L, Nielsen H, et al. Low efficacy and high frequency of adverse events in a randomized trial of the triple nucleoside regimen abacavir, stavudine and didanosine. AIDS. 2003;17(14):2045\u201352.","journal-title":"AIDS"},{"issue":"5","key":"63_CR44","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/ana.20816","volume":"59","author":"JA Pettersen","year":"2006","unstructured":"Pettersen JA, Jones G, Worthington C, Krentz HB, Keppler OT, Hoke A, et al. Sensory neuropathy in human immunodeficiency virus\/acquired immunodeficiency syndrome patients: protease inhibitor-mediated neurotoxicity. Ann Neurol. 2006;59(5):816\u201324.","journal-title":"Ann Neurol"},{"issue":"5","key":"63_CR45","doi-asserted-by":"crossref","first-page":"355","DOI":"10.7326\/0003-4819-126-5-199703010-00003","volume":"126","author":"SL Spruance","year":"1997","unstructured":"Spruance SL, Pavia AT, Mellors JW, Murphy R, Gathe J Jr, Stool E, et al. Clinical efficacy of monotherapy with stavudine compared with zidovudine in HIV-infected, zidovudine-experienced patients. A randomized, double-blind, controlled trial. Bristol-Myers Squibb Stavudine\/019 Study Group. Ann Intern Med. 1997;126(5):355\u201363.","journal-title":"Ann Intern Med"},{"key":"63_CR46","unstructured":"Centers for Disease Control and Prevention. Birth outcomes following zidovudine therapy in pregnant women. MMWR Morb Mortal Wkly Rep. 1994;43(22):409, 415\u20136."},{"key":"63_CR47","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1651-2227.1997.tb18327.x","volume":"421","author":"A White","year":"1997","unstructured":"White A, Eldridge R, Andrews E. Birth outcomes following zidovudine exposure in pregnant women: the Antiretroviral Pregnancy Registry. Acta Paediatr Suppl. 1997;421:86\u20138.","journal-title":"Acta Paediatr Suppl"},{"key":"63_CR48","unstructured":"Birth defect rates unchanged by antiretrovirals. AIDS Patient Care STDS. 2007;21(6):436."},{"issue":"2","key":"63_CR49","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1517\/14740338.4.2.323","volume":"4","author":"C Thorne","year":"2005","unstructured":"Thorne C, Newell ML. The safety of antiretroviral drugs in pregnancy. Expert Opin Drug Saf. 2005;4(2):323\u201335.","journal-title":"Expert Opin Drug Saf"},{"issue":"1","key":"63_CR50","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00002030-200101050-00025","volume":"15","author":"G Guaraldi","year":"2001","unstructured":"Guaraldi G, Ventura P, Albuzza M, Orlando G, Bedini A, Amorico G, et al. Pathological fractures in AIDS patients with osteopenia and osteoporosis induced by antiretroviral therapy. AIDS. 2001;15(1):137\u20138.","journal-title":"AIDS"},{"issue":"3","key":"63_CR51","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s12020-011-9586-7","volume":"41","author":"C Torti","year":"2012","unstructured":"Torti C, Mazziotti G, Soldini PA, Foca E, Maroldi R, Gotti D, et al. High prevalence of radiological vertebral fractures in HIV-infected males. Endocrine. 2012;41(3):512\u20137.","journal-title":"Endocrine"},{"issue":"5","key":"63_CR52","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2165\/00002018-200932050-00007","volume":"32","author":"A Pariente","year":"2009","unstructured":"Pariente A, Daveluy A, Laribiere-Benard A, Miremont-Salame G, Begaud B, Moore N. Effect of date of drug marketing on disproportionality measures in pharmacovigilance: the example of suicide with SSRIs using data from the UK MHRA. Drug Saf. 2009;32(5):441\u20137.","journal-title":"Drug Saf"}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-013-0063-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40264-013-0063-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-013-0063-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T17:52:59Z","timestamp":1715363579000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40264-013-0063-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,15]]},"references-count":52,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["63"],"URL":"https:\/\/doi.org\/10.1007\/s40264-013-0063-5","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,15]]}}}